Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Orzaks Ilac Ve Kimyanayi Ticaret AS EBITDA Margin %?
Orzaks Ilac Ve Kimyanayi Ticaret ASIST:ORZAX -1.41%18 EBITDA Margin % is 34.34% as of Dec. 2025, which is 13% above its 10-year median of 30.26. GuruFocus rates IST:ORZAX with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 1,962 Consumer Packaged Goods companies, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks better than 94.95% on this metric.
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Orzaks Ilac Ve Kimyanayi Ticaret AS EBITDA Margin % Related Terms
Orzaks Ilac Ve Kimyanayi Ticaret AS EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orzaks Ilac Ve Kimyanayi Ticaret AS EBITDA Margin % Chart
Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend
Dec23
Dec24
Dec25
EBITDA Margin %
22.74
30.26
34.34
Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
Dec23
Dec24
Dec25
EBITDA Margin %
22.74
30.26
34.34
IST:ORZAX vs KHC, GIS: EBITDA Margin % Comparison
For the Packaged Foods subindustry, Orzaks Ilac Ve Kimyanayi Ticaret AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orzaks Ilac Ve Kimyanayi Ticaret AS EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Orzaks Ilac Ve Kimyanayi Ticaret AS's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Orzaks Ilac Ve Kimyanayi Ticaret AS's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a EBITDA Margin % of 34.34% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. This is 13% above median its historical median of 30.26. Over the past decade, Orzaks Ilac Ve Kimyanayi Ticaret AS's EBITDA Margin % has ranged from 22.74 to 34.34. According to the industry distribution chart, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks #99 out of 1962 companies in the Consumer Packaged Goods industry, placing it in the top 5%.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's EBITDA Margin % too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current EBITDA Margin % of 34.34% is 13% above median its 10-year median of 30.26. Over the past 10 years, this metric has ranged from a low of 22.74 to a high of 34.34. The Consumer Packaged Goods industry median EBITDA Margin % is 8.96. Orzaks Ilac Ve Kimyanayi Ticaret AS's value of 34.34% is 283.5% above this industry median. Based on the distribution chart, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks #99 out of 1962 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks #99 out of 1962 companies for EBITDA Margin %. This places Orzaks Ilac Ve Kimyanayi Ticaret AS in the top 5% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.96. Orzaks Ilac Ve Kimyanayi Ticaret AS's value of 34.34% is 283.5% above this benchmark. Historically, Orzaks Ilac Ve Kimyanayi Ticaret AS's own EBITDA Margin % has ranged from 22.74 to 34.34 over the past decade. While the company's 10-year median is 30.26 vs. the industry median of 8.96, Orzaks Ilac Ve Kimyanayi Ticaret AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.96, based on 1,962 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orzaks Ilac Ve Kimyanayi Ticaret AS's current EBITDA Margin % of 34.34% is 283.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orzaks Ilac Ve Kimyanayi Ticaret AS's current EBITDA Margin % is 34.34%, which is 13% above median its own 10-year median of 30.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current EBITDA Margin % of 34.34%. The current EBITDA Margin % is 34.34%, which is 13% above median its 10-year median of 30.26 and 283.5% above the Consumer Packaged Goods industry median of 8.96. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current EBITDA Margin % is 34.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score
Get the complete analysis for IST:ORZAX
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ORZAX has been successfully added to your 
